About Helix BioPharma

Who We Are?

We are a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology for the prevention and treatment of cancer based on our proprietary technological platform DOS47.

DOS47 – Confirmed Mechanism of Action

Our Technology

aa7

Patented oncology platform technology to destroy cancer cells.

aa6

Designed to induce an increase in tumor pH.

aa5

Combat tumor acidity and restore immunity.

Latest News